ARK Genomic Revolution UCITS ETF Class A USD Accumulation | ARKGRegister to Unlock Ratings |
Performance History | 31/01/2025 |
Growth of 1,000 (GBP) | Advanced Graph |
![]() | Fund | - | - | - | - | 15.8 |
![]() | +/-Cat | - | - | - | - | 9.1 |
![]() | +/-B’mrk | - | - | - | - | 8.9 |
Category: Sector Equity Healthcare | ||||||
Category Benchmark: Morningstar Gbl Health TME ... |
Key Stats | ||
Closing Price 21/02/2025 | USD 5.18 | |
Day Change | -2.63% | |
Morningstar Category™ | Sector Equity Healthcare | |
Volume | 9084 | |
Exchange | LONDON STOCK EXCHANGE, THE | |
ISIN | IE000O5M6XO1 | |
Fund Size (Mil) - | - | |
Share Class Size (Mil) 20/02/2025 | USD 7.76 | |
Ongoing Charge 18/07/2024 | 0.75% |
Investment Objective: ARK Genomic Revolution UCITS ETF Class A USD Accumulation | ARKG |
The investment objective of the Fund is to generate long term capital growth (5 years or more). The Fund uses an active investment management strategy to achieve the Fund’s investment objective. The Fund will invest, under normal circumstances, primarily in global equity securities of companies across multiple sectors |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
- - | ||
Inception Date 12/04/2024 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI World NR USD | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for ARK Genomic Revolution UCITS ETF Class A USD Accumulation | ARKG | 20/02/2025 |
|
|
Top 5 Holdings | Sector | % |
![]() | ![]() | 9.02 |
![]() | ![]() | 8.38 |
![]() | ![]() | 7.70 |
![]() | ![]() | 7.47 |
![]() | ![]() | 5.03 |
![]() | ||
![]() ![]() ![]() | ||
ARK Genomic Revolution UCITS ETF Class A USD Accumulation | ARKG |